Literature DB >> 22772667

5-HT2 receptor distribution shown by [18F] setoperone PET in high-functioning autistic adults.

David Q Beversdorf1, Richard E Nordgren, Ali A Bonab, Alan J Fischman, Steven B Weise, Darin D Dougherty, Gretchen J Felopulos, Feng C Zhou, Margaret L Bauman.   

Abstract

The serotonergic system is implicated in disordered emotional behavior. Autism is characterized by impaired processing of emotional information. The serotonergic (5-HT) system is also critically involved in brain development, and abnormal brain synthesis of serotonin is observed in autism. Furthermore, whole blood and platelet serotonin have been reported to be elevated in autism. The authors examined the CNS serotonin system in autism in vivo. 5-HT2 receptors were visualized by PET imaging of [18F]setoperone-binding in this pilot study of 6 high-functioning autistic adults and 10 matched-control participants. Autism subjects had less thalamic [18F]setoperone binding than controls, when covaried for age, but no difference reached significance in other areas. A negative relationship between thalamic binding and history of language impairment was also observed. Further studies will be needed to gain a clearer picture of the role of the 5-HT system in autism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22772667     DOI: 10.1176/appi.neuropsych.11080202

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  11 in total

1.  Family-based clinical associations and functional characterization of the serotonin 2A receptor gene (HTR2A) in autism spectrum disorder.

Authors:  Ryan M Smith; Wesley Banks; Emily Hansen; Wolfgang Sadee; Gail E Herman
Journal:  Autism Res       Date:  2014-04-17       Impact factor: 5.216

Review 2.  Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment.

Authors:  Ansoo Lee; Hyunah Choo; Byungsun Jeon
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

Review 3.  The Roles of Serotonin in Neuropsychiatric Disorders.

Authors:  Mahsa Pourhamzeh; Fahimeh Ghasemi Moravej; Mehrnoosh Arabi; Elahe Shahriari; Soraya Mehrabi; Richard Ward; Reza Ahadi; Mohammad Taghi Joghataei
Journal:  Cell Mol Neurobiol       Date:  2021-03-02       Impact factor: 5.046

Review 4.  Structural, Functional, and Molecular Imaging of Autism Spectrum Disorder.

Authors:  Xiaoyi Li; Kai Zhang; Xiao He; Jinyun Zhou; Chentao Jin; Lesang Shen; Yuanxue Gao; Mei Tian; Hong Zhang
Journal:  Neurosci Bull       Date:  2021-03-29       Impact factor: 5.271

Review 5.  Translational Magnetic Resonance Imaging in Autism Spectrum Disorder From the Mouse Model to Human.

Authors:  Tomokazu Tsurugizawa
Journal:  Front Neurosci       Date:  2022-05-02       Impact factor: 4.677

6.  Interplay between maternal Slc6a4 mutation and prenatal stress: a possible mechanism for autistic behavior development.

Authors:  Calvin P Sjaarda; Patrick Hecht; Amy J M McNaughton; Audrina Zhou; Melissa L Hudson; Matt J Will; Garth Smith; Muhammad Ayub; Ping Liang; Nansheng Chen; David Beversdorf; Xudong Liu
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 7.  Biological Timing and Neurodevelopmental Disorders: A Role for Circadian Dysfunction in Autism Spectrum Disorders.

Authors:  Ethan Lorsung; Ramanujam Karthikeyan; Ruifeng Cao
Journal:  Front Neurosci       Date:  2021-03-12       Impact factor: 4.677

Review 8.  The Brain-Gut-Microbiome System: Pathways and Implications for Autism Spectrum Disorder.

Authors:  Michelle A Chernikova; Genesis D Flores; Emily Kilroy; Jennifer S Labus; Emeran A Mayer; Lisa Aziz-Zadeh
Journal:  Nutrients       Date:  2021-12-16       Impact factor: 5.717

9.  Phenotyping, Etiological Factors, and Biomarkers: Toward Precision Medicine in Autism Spectrum Disorders.

Authors:  David Q Beversdorf
Journal:  J Dev Behav Pediatr       Date:  2016-10       Impact factor: 2.225

10.  Serotonin transporter availability in adults with autism-a positron emission tomography study.

Authors:  Jacqueline Borg; Johan Lundberg; Max Andersson; Ämma Tangen; Lars Farde; Sven Bölte; Christer Halldin
Journal:  Mol Psychiatry       Date:  2020-08-26       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.